Amsterdam | October 27–28 | Booth S19
Mirava Bio will participate in the World Orphan Drug Congress Europe 2025, one of the leading global gatherings for rare-disease stakeholders, from innovators and regulators to patient advocates.
Join our CEO, Vincent Lévêque, during the Start-Up Pitches session on
📅 Tuesday, October 28 at 13:45, for his presentation:
“Breaking Barriers: Bringing Rare Disease Therapies to Patients in Europe”
We invite you to visit us at Booth S19 to discuss how Mirava Bio’s license-ready commercialization model is helping emerging biotechs expand into Europe, the Middle East, and Eurasia with speed, compliance, and purpose.
Let’s connect and explore how we can bring life-changing therapies to patients together.
👉 Contact us to book a meeting
Link: https://www.terrapinn.com/conference/world-orphan-drug-congress/exhibitor-mirava-bio.stm